Recent progress in the development of assays suited for histone deacetylase inhibitor screening

被引：26

作者：

Wegener, D ^{[1
]}

Hildmann, C ^{[1
]}

Schwienhorst, A ^{[1
]}

机构：

[1] Inst Mikrobiol & Genet, Abt Mol Genet & Praeparat Mol Biol, D-37077 Gottingen, Germany

来源：

MOLECULAR GENETICS AND METABOLISM | 2003年 / 80卷 / 1-2期

关键词：

D O I：

10.1016/j.ymgme.2003.08.008

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Histone deacetylase (HDAC) inhibitors have an unprecedented potential to occupy a major position in the future market of anticancer agents. However, progress in the development of these new chemotherapeutics is largely dependent on the existence of bioassays well-suited for inhibitor screening. Herein, we summarize recent developments in HDAC assay technology and, particularly, discuss different assay types with respect to their suitability for high-throughput screening programs. (C) 2003 Elsevier Inc. All rights reserved.

引用

页码：138 / 147

页数：10

共 85 条

[51] Fluorescence intensity multiple distributions analysis:: Concurrent determination of diffusion times and molecular brightness [J].

Palo, K ;

Metz, Ü ;

Jäger, S ;

Kask, P ;

Gall, K .

BIOPHYSICAL JOURNAL, 2000, 79 (06) :2858-2866

[52] HDAC's at work: Everyone doing their part [J].

Peterson, CL .

MOLECULAR CELL, 2002, 9 (05) :921-922

[53] Physical and functional interaction of SMADs and p300/CBP [J].

Pouponnot, C ;

Jayaraman, L ;

Massagué, J .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) :22865-22868

[54] Inhibitors of human histone deacetylase: Synthesis and enzyme and cellular activity of straight chain hydroxamates [J].

Remiszewski, SW ;

Sambucetti, LC ;

Atadja, P ;

Bair, KW ;

Cornell, WD ;

Green, MA ;

Howell, KL ;

Jung, M ;

Kwon, P ;

Trogani, N ;

Walker, H .

JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (04) :753-757

[55]

RICHON V, 2002, HISTONE DEACETYLASE

[56]

RIESTER D, 2003, UNPUB NOVEL THROMBIN

[57] Microarray deacetylation maps determine genome-wide functions for yeast histone deacetylases [J].

Robyr, D ;

Suka, Y ;

Xenarios, I ;

Kurdistani, SK ;

Wang, A ;

Suka, N ;

Grunstein, M .

CELL, 2002, 109 (04) :437-446

[58] A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors [J].

Saito, A ;

Yamashita, T ;

Mariko, Y ;

Nosaka, Y ;

Tsuchiya, K ;

Ando, T ;

Suzuki, T ;

Tsuruo, T ;

Nakanishi, O .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4592-4597

[59]

Saunders N, 1999, CANCER RES, V59, P399

[60]

Schmidt K, 1999, ARCH PHARM, V332, P353, DOI 10.1002/(SICI)1521-4184(199910)332:10<353::AID-ARDP353>3.0.CO

← 1 2 3 4 5 6 7 8 9 →